Purpose This study aimed to assess quality of life (QoL) in head and neck cancer (HNC) survivors and determine factors predictive of poor QoL in the first 5 years after the end of treatment. Methods A cross-sectional survey, including the Quality of Life in Adult Cancer Survivors (QLACS) measure, was sent to HNC survivors in three Scottish health regions, with responses linked to routinely collected clinical data. Independent sample t tests, ANOVAs, Pearson correlations and multiple hierarchical regressions were used to explore associations between and to determine the contribution made by demographic, lifestyle and clinical factors to predicting 'generic' and 'cancer-specific' quality of life. Results Two hundred eighty patients (65 %) returned questionnaires. After adjustment, multivariate analysis showed that younger age, lower socio-economic status, unemployment and self-reported comorbidity independently contributed to poorer generic and cancer-specific quality of life. In addition to these factors, having had a feeding tube or a diagnosis of oral cavity cancer were independently predictive of poorer cancer-specific quality of life. Conclusions Socio-economic factors and comorbidity are important predictors of QoL in HNC survivors. These factors and the detrimental long-term effects of feeding tubes need further attention in research and practice.
Introduction
Head and neck cancer (HNC) is the sixth most common cancer worldwide, and its incidence is rising. In the UK alone, a 51 % increase in male oral and oropharyngeal squamous cell carcinoma is mainly attributed to the rise in human papillomavirus (HPV) related cancers [1] . In Scotland, incidence rates are particularly high [2] . Low socio-economic status (SES), smoking, alcohol abuse, a lack of social support and poor psychological health are all strongly associated with increased incidence and poor prognosis [3, 4] . Patients with HNC therefore represent a vulnerable group.
In 2008, more than 1.5 million people with HNC worldwide were still alive up to 5 years after diagnosis [5] . In the UK, around 50 % of people with oral cancer and 60 % of people with laryngeal cancer now survive for 5 years or more [6] . Patients with HPV-related cancers respond more favourably to treatment, and the number living with HNC is likely to increase significantly over the next 10-20 years [7] . The needs and concerns of survivors are therefore of increasing relevance to the provision of long-term support.
The physical and psychosocial impact of HNC is considerable, as the consequences of treatment can include severe pain, fatigue, anxiety, depression, dry mouth, speech, swallowing and body image problems, among many others. Quality of life is fundamentally important, as patients experience significant changes in the acute phase of treatment, and many suffer longer term functional difficulties [8] [9] [10] . The negative psychosocial consequences of HNC can be equally enduring [11] . Quality of life has also been shown to predict survival in this patient group [12] .
The factors which influence poor quality of life (QoL) outcomes in people with HNC become increasingly important as healthcare systems consider how best to utilise finite resources in the follow-up care of a growing number of survivors. The concept of risk stratification has attracted much attention in the context of survivorship care, as it provides a means of quantifying the probability of adverse outcomes in a patient group and suggests which patients are likely to be at particular risk of poor outcomes, therefore enabling health care professionals to intervene appropriately [13] . Some predictors of poor QoL have been identified including feeding tubes [14] , pre-treatment QoL, comorbidity and stage [15] . However, most studies have used instruments designed to evaluate clinical trial outcomes, rather than more holistic measures of longterm quality of life.
The Quality of Life in Adult Cancer Survivors (QLACS) scale was developed specifically to elicit the issues relevant to people living with cancer in the longer term, including those with HNC [16, 17] . The QLACS conceptualization of cancerrelated quality of life comprises two key components: the ability to perform everyday activities reflecting physical, psychological and social well-being; and patient satisfaction with levels of functioning and control of their cancer [18] . The QLACS domains were considered highly relevant to HNC survivors as they included topics such as social avoidance, sexual concerns, financial problems, appearance and fear of recurrence as well as standard items such as pain and fatigue.
This cross-sectional study aimed to elicit the quality of life, concerns, unmet needs and distress associated with living with and beyond a diagnosis of HNC. This paper reports the QoL of HNC survivors who had completed treatment up to 5 years previously and illustrates which clinical and sociodemographic factors were predictive of poor quality of life. Data on unmet needs and concerns is reported elsewhere [19] .
Materials and methods

Data collection
A questionnaire booklet with reply envelope was posted to HNC survivors on the databases of Clinical Nurse Specialists (CNS) in three Scottish health boards. The booklet contained the QLACS [17] , the Distress Thermometer (DT) [20] , Patient Concerns Inventory (PCI) [21] and an unmet needs inventory adapted from the PCI. Questions were also asked about age, gender, nationality, relationship status, living arrangements, current smoking and drinking habits, treatment type, feeding tube use, employment status and comorbidities.
Participants over 18 were eligible if they had completed treatment between 3 months and 5 years before the survey was mailed. Survivors were excluded by the CNS if they were receiving palliative care, had a prognosis of <6 months, did not speak English or were considered likely to find the survey distressing.
Anonymised questionnaires, identified only by study number, were returned to the researchers. CNS sent reminder letters to potential participants who had not returned their questionnaire within 4 weeks. Data collection took place between May and December 2011. Ethical approval was granted by the Tayside Committee on Medical Ethics.
Study numbers and corresponding unique 10-digit community health index (CHI) numbers were submitted by CNS to the Health Informatics Centre (HIC -http://www.dundee.ac. uk/HIC), which holds routine clinical datasets, including cancer registry hospital admission records, on every cancer patient registered with a general practitioner (GP) in two of the participating health board regions. International Classification of Diagnosis (ICD 10) codes for diagnosis, UICC stage, date of diagnosis and Scottish Index of Multiple Deprivation (SIMD) indices based on home postcode were linked to questionnaire data for all participants. Because HIC did not hold routine data for our third participating region, the required clinical and socio-demographic information was transferred from the CNS to HIC using a secure mechanism. Time from diagnosis was calculated from cancer registry or CNS records to the date of survey completion. The extended dataset was anonymised and made available to the research team via a secure data safe haven.
The QLACS scale consists of 47 Likert scale items. Patients evaluate statements with reference to the preceding 4 weeks, indicating how frequently (from 'never' to 'always') the statements have applied to them. Questions can be summed to produce domain scores for generic QoL (including sub-scales for negative feelings, positive feelings, cognitive problems, sexual problems, physical pain, fatigue and social avoidance), cancer-related QoL (including sub-scales for appearance concerns, financial problems, distress over recurrence and family-related distress) and benefits of cancer.
Summary domain scores range from 4 to 28, with higher scores indicating negative outcomes (low QoL) for all domains except for the 'positive feelings' and 'benefits' domains (for which higher scores indicate positive outcomes (high QoL). Evaluation of the test-retest reliability, internal consistency, validity and sensitivity to change of QLACS has shown that its overall reliability is high [16, 17] .
Statistical analysis
Differences between responders and non-responders were tested using chi-squared tests for categorical variables. Data were described as number of subjects (percentages) for categorical variables and mean (standard deviation) for continuous variables or where the distribution was skewed, median and inter-quartile range (IQR). Blank responses in the QLACS questionnaire were handled using case-mean substitution [22] and sub-scales and domains were scored using published procedures [17] . Independent sample t tests and ANOVAs were run to explore the associations between domain scores for generic and cancer-specific quality of life and (i) demographic factors-gender, age, SIMD and living arrangements; (ii) lifestyle factors-smoking status, alcohol status and employment status; (iii) clinical factors-diagnosis (larynx, oropharynx, oral cavity or other), length of time since diagnosis, type of treatment (surgery alone or treatment including radiotherapy or chemotherapy), UICC stage and whether or not feeding tube had ever been fitted. Pearson correlations were run to explore the association between domain scores for generic and cancer-specific QoL and number of comorbidities (selfreported). Hierarchical multiple regressions were conducted to test the contribution of the demographic, lifestyle and clinical factors to predicting (i) cancer-specific QoL and (ii) generic QoL. Dummy variables were created for diagnosis-oropharynx, oral cavity and other site, with the larynx dummy variable as the reference. UICC stage was not entered into the regressions because of the high proportion of missing data. Where the distribution was skewed, differences in continuous variables were examined using a Mann-Whitney test or a Kruskal-Wallis test. All statistical analyses were performed using IBM SPSS Version 23.
Results
Four hundred and eighty-eight questionnaires were distributed and 319 (65 %) returned. The socio-demographic characteristics of responders versus non-responders were compared, with no differences in response by gender, age or time since diagnosis. However, the response rate was significantly better for patients from the highest SES group (SIMD 5) (83 %) compared to 53 % from the lowest (SIMD 1) (p<0.0001).
Of the 319 questionnaires returned, 39 were from people who had completed treatment more than 5 years previously and so were outside the time period defined for the cohort. There were some missing data in the remaining 280, but 264 had completed enough items to be scored on the cancerspecific summary score and 259 on the generic summary score.
The main demographic, lifestyle and clinical characteristics are shown in Table 1 . Participants were aged between 27 and QLACS scores for generic and cancer-specific QoL were positively skewed, illustrating that the majority of survivors deemed their quality of life to be good, although a tail of poorly scoring participants clearly existed. Median summary scores for individual sub-scales varied, with the lowest (best) median score for 'financial problems' and highest (worst) for 'distress-recurrence' and 'fatigue' ( Table 2) .
Predictors of cancer-specific quality of life
There were significant differences in mean cancer-specific QoL scores by gender (t(260) = −2.635, p = 0.009), age (F(4259) = 6.047, p < 0.001), SIMD (F(4259) = 4.067, p = Table 3) . Posthoc analysis revealed that participants who were retired had significantly higher cancer-specific QoL scores than participants who were in employment or out of work (Table 3) . Patients with oral cavity cancer had significantly worse cancer-specific QoL scores than patients with cancer of the larynx (Table 3 ). There was a significant correlation between cancer-related QoL and number of comorbidities (r=0.232, p<0.001). Hierarchical multiple regression analysis revealed that demographic, lifestyle and clinical factors predicted 33.7 % of the variance in cancer-specific QoL score (F(14, 226)=8.206, p<0.001). Being younger, having a lower socioeconomic status, being out of work, having a greater number of comorbidities, having ever had a feeding tube fitted and having a diagnosis of oral cavity cancer all independently contributed to poorer cancer-specific QoL based on the score (Table 4) .
Predictors of generic quality of life
There were significant differences in mean generic (Table 4) .
Sub-scale analysis
Given that the significant effects of ever having had a feeding tube fitted and type of diagnosis appeared to be on the cancerspecific QoL score rather than the generic score, we investigated the relationship between feeding tube and individual sub-scales which contribute to the cancer-specific summary score (appearance concerns, financial problems, distress over recurrence, family-related distress and benefits of cancer) to see whether the effects might be associated with particular sub-scales. Median scores were significantly higher (worse) for participants who had ever had a feeding tube fitted in the appearance concerns, financial problems and family-related distress sub-scales. Median scores differed significantly by type of diagnosis in the appearance and distress over recurrence sub-scales, with oral cavity cancer scoring the highest (worse QoL) in both sub-scales (Table 5 ). In the regression analysis for both generic and cancerspecific QoL, lower SES was found to be a significant predictor of having worse QoL scores. In order to investigate whether there was a relationship between SES and particular subscales, we explored the median scores and inter-quartile ranges for each sub-scale (Table 6 ). Scores were consistently higher (worse) in the most deprived groups across all subscales; however, there was only a statistically significant difference between SIMD groups in the physical pain and fatigue sub-scales.
Discussion
This cross-sectional study investigated the quality of life of survivors of head and neck cancer in the first 5 years after the end of treatment. Our first key finding is that, after controlling for clinical and socio-demographic factors, low socioeconomic status, being out of work, having a greater number of comorbidities and being younger are independent predictors of reduced cancer-specific and generic quality of life in HNC survivors. The second key finding of our study was that having a diagnosis of oral cavity cancer and ever having had a feeding tube fitted were also independent predictors of reduced cancer-specific quality of life.
Unadjusted analyses suggest that differences in individual QoL domains, particularly those that are specific to cancer, may exist between groups, with survivors of oral cancer having poorer scores than those with oropharyngeal or laryngeal cancers. Smoking, age, gender, unemployment, low socioeconomic status and having a feeding tube appear to have a detrimental effect on cancer-specific and generic QoL, whereas drinking some alcohol appeared to improve the latter.
Patients with head and neck cancer are assumed to be difficult to reach; however, we achieved a response rate similar to that of the English patient experience survey, which gathered postal data from survivors of other more common cancers [23] . We also found that people of lower SES were significantly less likely to respond, but in our study, there was no difference in the age of responders versus non-responders. Our QLACS scores were slightly lower (better) than the sample in Avis et al.'s [17] study, but they are not directly comparable because the authors reported mean rather than median scores.
There is a well-established link between survival and low socio-economic status, although recent studies have found that neighbourhood deprivation may not be an independent predictor across all HNC types [24, 25] . This could suggest that the measure of deprivation is acting as a confounder for other unmeasured factors. Our research confirms the results of several studies establishing an association between [26, 27] . An under-powered Turkish study [26] found that after controlling for other factors, only 'social security status' remained a significant predictor of a mental health QoL score. Our study may therefore be the first with sufficient power to establish that low SES is associated with reduced quality of life in HNC survivors. We also found that common symptoms including pain and fatigue appear to be significantly worse in people from poorer socio-economic backgrounds, suggesting that careful symptom assessment and management may be even more important in this group. There are a range of complex reasons why low SES may adversely affect outcomes in survivors of cancer [28] , and these apply to head and neck as much as any other cancer. For example, a large survey found a significant link between deprivation, psychological distress and, to a lesser extent, social difficulties [29] . People who are socially deprived are more likely to suffer from a number of comorbid conditions [30] and make greater use of (4) 12 (11) 6 (9) 16 (12) health services than people in higher socio-economic groups [31] . A recent review [32] shows that comorbidity is associated with poorer outcomes (including quality of life) in people with HNC and suggests that comorbidity data should be routinely collected by clinical teams. Although this is the ideal, our own findings support the potential for self-report of comorbid conditions [33] .
Other studies have found that the presence of a gastrostomy tube at 1-year post treatment was associated with poorer quality of life [14, 15] , but we found an independent effect for having a feeding tube at any time during the follow-up period assessed. Most patients treated with chemo-radiation require a feeding tube during or after treatment, and early nutritional intervention is widely regarded as important [34] . However, the choice of enteral route and the timing of insertion are controversial. A recent systematic review [35] concluded that gastrostomy tubes, in particular, may inhibit swallowing function. Our data add further evidence that the long-term consequences of feeding tubes should not be under-estimated and that there are particularly detrimental effects on appearance, family and finances, although the direction of this relationship is unclear. We acknowledge that maintaining adequate nutrition in this patient group is challenging, and further research is required to determine the long-term impact of feeding tubes and to specify the pathways by which a feeding tube might affect quality of life.
Whereas smoking was associated with worse QoL in unadjusted analysis (as in other studies e.g. [36] ), drinking some alcohol appeared to be protective. Social drinking has previously been associated with improved quality of life although problem drinkers have the worst outcomes of all [37, 38] . We did not detect a difference between light/moderate and heavy drinkers, but this may reflect inaccurate self-reporting by our participants.
Our data suggest that being unemployed adversely affects QoL. Patients with HNC appear to have more problems returning to work than patients with other cancers [39, 40] . Barriers include anxiety, difficulties with social interaction and social eating, oral and dental problems, although in a recent Dutch study, 83 % still returned to work [41] . Working after cancer has a range of benefits including financial security, confidence and self-identity, but qualitative studies illustrate the numerous challenges and changes that people experience in the workplace, and there is a real need to develop interventions that are tailored to individuals' work-related goals [42] . This is one of the few cross-sectional studies in HNC to use a measure designed to assess quality of life beyond the acute stages of diagnosis and treatment and to link patient-reported outcomes to reliable routinely collected clinical and socio-economic data. There are, however, a number of limitations to this study. Firstly, cross-sectional studies only provide a snapshot of QoL, cannot assess change over time and demonstrate associations not causality. Their results are inevitably biased towards those patients with the most favourable survival as they exclude people who have already died (24) . Secondly, the representativeness of the survey cannot be assumed. Although questionnaires were sent to as many patients as the CNS' could identify from their databases, which ensured a clinically heterogeneous sample of patients with different cancers and time from diagnosis, it is likely that some potential participants were not sent questionnaires. It is also possible that the quality of life of responders was different to that of non-responders. Some patients commented that scoring QoL based on the 'last four weeks' (as per the wording of the questionnaire) was difficult, as issues were not necessarily relevant to the last month but had been relevant at other times. UICC stage data was missing for 25 % of the sample, and because of this, cancer stage was excluded from the regression analyses. There was no significant difference in univariate analysis of cancer and generic quality of life scores between participants with different stages of cancer (Table 3) . However, to ensure accuracy for audit and research, efforts need to be made to capture cancer stage on cancer registries and databases for all cancer patients. Finally, there is a risk that multiple comparisons could generate some false positive results. Further research is required to prospectively assess relationships between the variables we have identified.
There are a number of clinical implications arising from this study. Our results suggest that factors associated with poor QoL among survivors can be identified and used to direct support to those in most need. Data on SES may not be routinely available to clinicians, and sensitivity is required if people from lower socio-economic groups are to be targeted for additional attention. However, our study suggests that it is important to consider the 'double whammy' of head and neck cancer treatment in addition to the material, psychosocial, environmental, behavioural, intellectual, cultural and physical effects of low SES and that individualised holistic assessment is particularly important in this patient group. Clinicians providing follow-up care should also be aware that feeding tubes may be associated with long-term consequences on quality of life that are not necessarily directly linked to problems with eating and swallowing.
Conclusion
Many head and neck cancer survivors experience poor quality of life in the first 5 years after treatment. This cross-sectional study shows that younger age, unemployment, low socioeconomic status, increased comorbidity and having a feeding tube are important predictors of poor quality of life in this patient group. These factors must be considered more carefully in research and practice, with greater attention paid to the needs of survivors who are most at risk.
